Chromadex Corp Stock
Chromadex Corp Stock
Chromadex Corp gained 0.630% compared to yesterday.
We see a rather positive sentiment for Chromadex Corp with 11 Buy predictions and 1 Sell predictions.
With a target price of 5 € there is a hugely positive potential of 58.23% for Chromadex Corp compared to the current price of 3.16 €.
Our community identified positive and negative aspects for Chromadex Corp stock for the coming years. 0 users see the criterium "EBIT Margin" as a plus for the Chromadex Corp stock. On the other hand our users think that "EBIT Margin" could be a problem in the future.
Pros and Cons of Chromadex Corp in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
B****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Chromadex Corp vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Chromadex Corp | 0.630% | -9.714% | -17.277% | 135.821% | 135.821% | -44.561% | - |
Organovo Holdings Inc. | 1.250% | 7.243% | -3.774% | -44.964% | -10.526% | -83.752% | -94.694% |
Intellia Therapeutics Inc | 1.440% | 7.066% | 4.205% | -40.451% | -17.824% | -56.887% | 71.151% |
VBI Vaccines Inc. | 2.990% | 6.352% | 5.967% | -79.293% | 10.566% | -99.106% | -98.944% |
Comments
ChromaDex Co. (NASDAQ: CDXC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) had its price target raised by analysts at Roth Mkm from $4.25 to $6.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat